Skip to main content

Association of human leukocyte antigen DRB1 polymorphism and tuberculosis: a meta-analysis

Buy Article:

$34.78 + tax (Refund Policy)

OBJECTIVE: To determine whether the human leukocyte antigen DRB1 (HLA-DRB1) is associated with clinical tuberculosis (TB).

METHODS: Pooled odds ratios (OR) with 95% confidence intervals (CIs) were used to evaluate the strength of the association between HLA-DRB1 alleles and risk of TB. The χ2-based Q-test and I 2 statistics were calculated to examine heterogeneity. Egger's test was performed for the assessment of publication bias. Subgroup analysis was performed based on ethnicity and genotyping methods.

RESULTS: A total of 19 case-control studies with 16 alleles (HLA-DRB1*01–HLA-DRB1*16) were included in this meta-analysis. No significant publication bias was detected among these studies. The HLA-DRB1*03 (OR 0.77, 95%CI 0.64–0.93, P = 0.0057) showed a protective effect, while HLA-DRB1*04 (OR 1.24, 95%CI 1.00–1.55, P = 0.0494), HLA-DRB1*08 (OR 1.45, 95%CI 1.14–1.86, P = 0.0030) and HLA-DRB1*16 (OR 1.39, 95%CI 1.04–1.87, P = 0.0269) were significantly associated with increased TB occurrence. Subgroup analysis showed that both ethnicity and genotyping method affected the association between HLA-DRB1*03, HLA-DRB1*04 and HLA-DRB1*08 alleles and TB occurrence.

CONCLUSION: These results reinforce the importance of HLA-DRB1 alleles in the development of infectious diseases.

Keywords: TB; gene polymorphism; human leukocyte antigen DRB1 (HLA-DRB1); meta-analysis

Document Type: Research Article

Affiliations: Second Department of Orthopedics, Second Affiliated Hospital of Xi'an Jiaotong University Medical School, Shaanxi, China

Publication date: 01 January 2016

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content